Παρασκευή 31 Μαρτίου 2017

Multicystic peritoneal mesothelioma: A short review

alertIcon.gif

Publication date: Available online 31 March 2017
Source:Current Problems in Cancer
Author(s): Chi-hao Zhang, Ji-wei Yu, Meng Luo
Multicystic peritoneal mesothelioma (MCPM) is a rare neoplasm, predominantly affecting female patients during their reproductive years. The lesion is usually distributed diffusely in the abdomen and pelvis, but the peritoneum of the pelvic organs is the most common site. MCPM is composed of fluid-filled translucent cysts, connected by varying amounts of fibrous tissue, and lined by a layer of mesothelial cells. Due to the rarity of this disease, the pathogenesis and natural history of MCPM remain poorly understood and continuously debated. Some authors consider it to be a reactive process for its association with prior surgery or abdominal inflammation. But its high rate of local-regional recurrence, as well as its malignant potential, has others suggest a neoplastic aetiology. Preoperative diagnosis is often very difficult. Imaging methods, such as ultrasound, computed tomography and magnetic resonance imaging, are of little value for an accurate diagnosis of MCPM. The definitive diagnosis relies on histological examination of target lesions combined with immunohistochemical stains. There is no consensus on the clinical management of MCPM, although surgical removal remains the first-line treatment of choice. But no standards have been reached concerning which surgical options, traditional debulking surgery or more aggressive one, should be chosen. Alternative therapeutic approaches include hand-off treatment, hormonal supplementation, laser vaporization, and sclerotherapy, and they all come with uncertain results. Moreover, the lesions show no response to adjuvant chemotherapy and radiotherapy. This article aims to focus on those controversial problems in term of pathogenesis, natural history, diagnosis and treatment strategies to help medical workers to better understand this rare disease.



http://ift.tt/2nHRU2i

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου